Lexaria Bioscience (LEXX) provides the following final primary and major secondary efficacy endpoint results update on its Phase 1b, 12-week ...

Lexaria says its oral GLP-1 cut total adverse events nearly 48% versus Novo's Rybelsus, with comparable HbA1c results in a Phase 1b study.

These findings are very encouraging relative to Lexaria's separate program interests in pursuing development of DHT-CBD for the treatment of hypertensive patients. Lexaria has earlier received FDA ...

Dihydrotestosterone, also known as DHT, is a hormone crucial in issues such as hair loss, acne, and prostate-related concerns. It is essential for developing masculine characteristics, but an excess ...

This article was reviewed by Knox Beasley, MD. If you’ve noticed the signs of male pattern baldness — say, a thinning hairline or a bald patch on the crown of your head — a hormone called DHT is ...

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...